Among the five squamous cell carcinoma, five mammary adenocarcinoma, five fibrosarcoma, and three renal cell carcinoma samples tested, PD-L1 was detected in tumor cells of five (100%), four (80%), five (100%), and three (100%) samples, respectively (Fig 5c–5e, Table 3). This evidence concerns the gene CD274 and squamous cell carcinoma.